Logo image of NXE

NEXGEN ENERGY LTD (NXE) Stock Fundamental Analysis

NYSE:NXE - New York Stock Exchange, Inc. - CA65340P1062 - Common Stock - Currency: USD

6.02  -0.16 (-2.59%)

After market: 6.02 0 (0%)

Fundamental Rating

2

Taking everything into account, NXE scores 2 out of 10 in our fundamental rating. NXE was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of NXE have multiple concerns. NXE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NXE had negative earnings in the past year.
In the past year NXE has reported a negative cash flow from operations.
In the past 5 years NXE reported 4 times negative net income.
NXE had a negative operating cash flow in each of the past 5 years.
NXE Yearly Net Income VS EBIT VS OCF VS FCFNXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

NXE has a Return On Assets of -5.99%. This is in the lower half of the industry: NXE underperforms 78.87% of its industry peers.
Looking at the Return On Equity, with a value of -8.51%, NXE is doing worse than 73.24% of the companies in the same industry.
Industry RankSector Rank
ROA -5.99%
ROE -8.51%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
NXE Yearly ROA, ROE, ROICNXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NXE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE Yearly Profit, Operating, Gross MarginsNXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

NXE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NXE has been increased compared to 5 years ago.
NXE has a worse debt/assets ratio than last year.
NXE Yearly Shares OutstandingNXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NXE Yearly Total Debt VS Total AssetsNXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

NXE has an Altman-Z score of 5.86. This indicates that NXE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.86, NXE belongs to the best of the industry, outperforming 90.61% of the companies in the same industry.
NXE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, NXE belongs to the best of the industry, outperforming 83.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.86
ROIC/WACCN/A
WACCN/A
NXE Yearly LT Debt VS Equity VS FCFNXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.97 indicates that NXE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.97, NXE is in line with its industry, outperforming 40.38% of the companies in the same industry.
A Quick Ratio of 0.97 indicates that NXE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.97, NXE is in line with its industry, outperforming 50.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
NXE Yearly Current Assets VS Current LiabilitesNXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

NXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.52%, which is quite impressive.
EPS 1Y (TTM)65.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NXE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.40% yearly.
The Revenue is expected to grow by 195.69% on average over the next years. This is a very strong growth
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y2.4%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y195.69%

3.3 Evolution

NXE Yearly Revenue VS EstimatesNXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2028 2029 2030 2031 2032 1B 2B 3B
NXE Yearly EPS VS EstimatesNXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.
Also next year NXE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE Price Earnings VS Forward Price EarningsNXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE Per share dataNXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

NXE's earnings are expected to decrease with -2.19% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.51%
EPS Next 3Y-2.19%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXGEN ENERGY LTD

NYSE:NXE (6/2/2025, 7:13:59 PM)

After market: 6.02 0 (0%)

6.02

-0.16 (-2.59%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners52.62%
Inst Owner Change7.61%
Ins Owners4.63%
Ins Owner ChangeN/A
Market Cap3.43B
Analysts81.05
Price Target9.91 (64.62%)
Short Float %15.76%
Short Ratio7.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)41.07%
Min EPS beat(2)-159.31%
Max EPS beat(2)241.44%
EPS beat(4)3
Avg EPS beat(4)46.25%
Min EPS beat(4)-159.31%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-51.8%
EPS beat(12)4
Avg EPS beat(12)-131.16%
EPS beat(16)4
Avg EPS beat(16)-158.46%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.66%
PT rev (3m)-2.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.27%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.29
P/tB 4.29
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS1.4
TBVpS1.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.99%
ROE -8.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5461.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 5.86
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5324.66%
Cap/Depr(5y)3796.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y2.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y195.69%
EBIT growth 1Y45.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.72%
EBIT Next 3Y3.55%
EBIT Next 5Y9.76%
FCF growth 1Y-41.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.5%
OCF growth 3YN/A
OCF growth 5YN/A